BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 2842506)

  • 1. Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
    Griengl H; Hayden W; Penn G; De Clercq E; Rosenwirth B
    J Med Chem; 1988 Sep; 31(9):1831-9. PubMed ID: 2842506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus.
    De Clercq E; Rosenwirth B
    Antimicrob Agents Chemother; 1985 Aug; 28(2):246-51. PubMed ID: 3010841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-(Haloalkyl)-2'-deoxyuridines: a novel type of potent antiviral nucleoside analogue.
    Griengl H; Bodenteich M; Hayden W; Wanek E; Streicher W; Stütz P; Bachmayer H; Ghazzouli I; Rosenwirth B
    J Med Chem; 1985 Nov; 28(11):1679-84. PubMed ID: 4067994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
    J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'-Fluorinated arabinonucleosides of 5-(2-haloalkyl)uracil: synthesis and antiviral activity.
    Griengl H; Wanek E; Schwarz W; Streicher W; Rosenwirth B; De Clercq E
    J Med Chem; 1987 Jul; 30(7):1199-204. PubMed ID: 3037079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines.
    Herdewijn P; De Clercq E; Balzarini J; Vanderhaeghe H
    J Med Chem; 1985 May; 28(5):550-5. PubMed ID: 2985782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
    Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
    Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of 5'-PAA and 5'-PFA phosphate esters of 2'-deoxyuridines.
    Bird RM; Broadhurst AV; Duncan IB; Hall MJ; Lambert RW; Wong-Kai-In P
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():201-5. PubMed ID: 2947889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
    De Clercq E; Bernaerts R; Merta A; Rosenwirth B
    Mol Pharmacol; 1990 May; 37(5):658-64. PubMed ID: 2160059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
    Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
    J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
    Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
    Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
    De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
    J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral properties of 5-(2-substituted vinyl)-6-aza-2'-deoxyuridines.
    Mitchell WL; Ravenscroft P; Hill ML; Knutsen LJ; Judkins BD; Newton RF; Scopes DI
    J Med Chem; 1986 May; 29(5):809-16. PubMed ID: 3009815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic and antimutagenic effects of 5-substituted 2'-deoxyuridines depending on the nature of the 5-substituent.
    Marquardt H; Westendorf J; Schaefer A; Boldt J; De Clercq E; Marquardt H
    Arzneimittelforschung; 1988 Dec; 38(12):1820-4. PubMed ID: 3072958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.